NCT02422823View on ClinicalTrials.gov

Anesthetic Efficacy of 1,8mL and 3,6mL of Articaine in Inferior Alveolar Nerve Block in Irreversible Pulpitis

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Pulpitis
Interventions
DRUG

Articaine

Injection of 1.8mL of 4% articaine with 1: 100,000 epinephrine in block the inferior alveolar nerve in patients with irreversible pulpitis of mandibular molar in 40 patients

DRUG

Articaine

Injection of 3.6mL of 4% articaine with 1: 100,000 epinephrine in block the inferior alveolar nerve in patients with irreversible pulpitis of mandibular molar in 40 patients

DRUG

Epinephrine

Trial Locations (1)

05508-000

Faculdade de Odontologia da USP, São Paulo

All Listed Sponsors
lead

Isabel Peixoto Tortamano

OTHER

NCT02422823 - Anesthetic Efficacy of 1,8mL and 3,6mL of Articaine in Inferior Alveolar Nerve Block in Irreversible Pulpitis | Biotech Hunter | Biotech Hunter